Multiple sclerosis trials in Türkiye

1 of 2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  Where

  Samsun

  Age

  10 years to 17 years

  People

  194 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06408259 · EU 2022-501332-42-00